Neovasc Investor Relations Material
Latest events
Q3 2022
Neovasc
Q4 2022
31 Mar, 2023
Corporate Strategy Update
11 Nov, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Neovasc Inc
Access all reports
Neovasc Inc. is a medical device company that focuses on the development of products for the treatment of cardiovascular diseases. The company's primary offerings include devices designed to address refractory angina, a chronic condition characterized by chest pain, and to support heart valve repair procedures. The company is headquartered in Richmond, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
NVCN
Country
🇨🇦 Canada